# EDGAR Filing Document

**Accession Number:** 0001446159
**File Stem:** 0002116919-26-000003
**Filing Date:** 2026-4
**Character Count:** 12372
**Document Hash:** 9425b57016ec8b62bf79271f902f5beb
**Contains OCR:** False
**Source Format:** 

## Filing Content

## Filing Summary
**0002116919-26-000003.hdr.sgml**: 20260416

**ACCESSION NUMBER**: 0002116919-26-000003

**CONFORMED SUBMISSION TYPE**: SCHEDULE 13D

**PUBLIC DOCUMENT COUNT**: 6

**FILED AS OF DATE**: 20260416

**DATE AS OF CHANGE**: 20260416

**SUBJECT COMPANY**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** Axe Compute Inc.
- **CENTRAL INDEX KEY:** 0001446159
- **STANDARD INDUSTRIAL CLASSIFICATION:** ORTHOPEDIC, PROSTHETIC & SURGICAL APPLIANCES & SUPPLIES [3842]
- **ORGANIZATION NAME:** 08 Industrial Applications and Services
- **EIN:** 331007393
- **STATE OF INCORPORATION:** DE
- **FISCAL YEAR END:** 1231

**FILING VALUES:**
- **FORM TYPE:** SCHEDULE 13D
- **SEC ACT:** 1934 Act
- **SEC FILE NUMBER:** 005-86172
- **FILM NUMBER:** 26866509

**BUSINESS ADDRESS:**
- **STREET 1:** 91 43RD STREET
- **STREET 2:** SUITE 110
- **CITY:** PITTSBURGH
- **STATE:** PA
- **ZIP:** 15201
- **BUSINESS PHONE:** 412-432-1500

**MAIL ADDRESS:**
- **STREET 1:** 91 43RD STREET
- **STREET 2:** SUITE 110
- **CITY:** PITTSBURGH
- **STATE:** PA
- **ZIP:** 15201

**FORMER COMPANY:**
- **FORMER CONFORMED NAME:** Predictive Oncology Inc.
- **DATE OF NAME CHANGE:** 20190612

**FORMER COMPANY:**
- **FORMER CONFORMED NAME:** Precision Therapeutics Inc.
- **DATE OF NAME CHANGE:** 20180314

**FORMER COMPANY:**
- **FORMER CONFORMED NAME:** Precision Therapeutic Inc.
- **DATE OF NAME CHANGE:** 20180208
**FILED BY**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** Okamoto Kyle Robert
- **CENTRAL INDEX KEY:** 0002116919

**ORGANIZATION NAME:**

**FILING VALUES:**
- **FORM TYPE:** SCHEDULE 13D

**MAIL ADDRESS:**
- **STREET 1:** 6 CHINA LANE
- **CITY:** SETAUKET
- **STATE:** NY
- **ZIP:** 11733

### Attached PDF Documents

**Attachment 1:** `ex99-1.pdf`

_No text found in this document._

**Attachment 2:** `ex99-4.pdf`

_No text found in this document._

**Attachment 3:** `ex99-5.pdf`

_No text found in this document._

**Attachment 4:** `ex99-2.pdf`

_No text found in this document._

**Attachment 5:** `ex99-3.pdf`

_No text found in this document._

### UNITED STATES SECURITIES AND EXCHANGE COMMISSION
**Washington, D.C. 20549**

## SCHEDULE 13D

### Under the Securities Exchange Act of 1934

**Axe Compute Inc.**

*(Name of Issuer)*

**Common Stock**

*(Title of Class of Securities)*

**—**

*(CUSIP Number)*

**Kyle Okamoto**<br>6 China Lane<br>Setauket NY 11733<br>6464384333

*(Name, Address and Telephone Number of Person Authorized to Receive Notices and Communications)*

**12/07/2025**

*(Date of Event Which Requires Filing of this Statement)*

| **CUSIP No.** | **—** |

---

| | | | |
|:--|:--|:--|:--|
| 1 | Name of reporting person<br>**Okamoto Kyle Robert** | Name of reporting person<br>**Okamoto Kyle Robert** | |
| 2 | Check the appropriate box if a member of a Group (See Instructions)<br>[x] (a)<br>[ ] (b) | Check the appropriate box if a member of a Group (See Instructions)<br>[x] (a)<br>[ ] (b) | |
| 3 | SEC use only | SEC use only | |
| 4 | Source of funds (See Instructions)<br>**OO** | Source of funds (See Instructions)<br>**OO** | |
| 5 | Check if disclosure of legal proceedings is required pursuant to Items 2(d) or 2(e)<br>[ ] | Check if disclosure of legal proceedings is required pursuant to Items 2(d) or 2(e)<br>[ ] | |
| 6 | Citizenship or place of organization<br>**X1** | Citizenship or place of organization<br>**X1** | |
| Number of Shares<br>Beneficially Owned by<br>Each Reporting Person With: | 7 | Sole Voting Power<br>**244389.00** |
| Number of Shares<br>Beneficially Owned by<br>Each Reporting Person With: | 8 | Shared Voting Power<br>**0.00** |
| Number of Shares<br>Beneficially Owned by<br>Each Reporting Person With: | 9 | Sole Dispositive Power<br>**244389.00** |
| Number of Shares<br>Beneficially Owned by<br>Each Reporting Person With: | 10 | Shared Dispositive Power<br>**0.00** |
| 11 | Aggregate amount beneficially owned by each reporting person<br>**244389.00** | Aggregate amount beneficially owned by each reporting person<br>**244389.00** | |
| 12 | Check if the aggregate amount in Row (11) excludes certain shares (See Instructions)<br>[ ] | Check if the aggregate amount in Row (11) excludes certain shares (See Instructions)<br>[ ] | |
| 13 | Percent of class represented by amount in Row (11)<br>**4.4%** | Percent of class represented by amount in Row (11)<br>**4.4%** | |
| 14 | Type of Reporting Person (See Instructions)<br>**IN** | Type of Reporting Person (See Instructions)<br>**IN** | |

---

| **CUSIP No.** | **—** |

---

| | | | |
|:--|:--|:--|:--|
| 1 | Name of reporting person<br>**Okalina Ventures LLC** | Name of reporting person<br>**Okalina Ventures LLC** | |
| 2 | Check the appropriate box if a member of a Group (See Instructions)<br>[x] (a)<br>[ ] (b) | Check the appropriate box if a member of a Group (See Instructions)<br>[x] (a)<br>[ ] (b) | |
| 3 | SEC use only | SEC use only | |
| 4 | Source of funds (See Instructions)<br>**OO** | Source of funds (See Instructions)<br>**OO** | |
| 5 | Check if disclosure of legal proceedings is required pursuant to Items 2(d) or 2(e)<br>[ ] | Check if disclosure of legal proceedings is required pursuant to Items 2(d) or 2(e)<br>[ ] | |
| 6 | Citizenship or place of organization<br>**NEW YORK** | Citizenship or place of organization<br>**NEW YORK** | |
| Number of Shares<br>Beneficially Owned by<br>Each Reporting Person With: | 7 | Sole Voting Power<br>**244389.00** |
| Number of Shares<br>Beneficially Owned by<br>Each Reporting Person With: | 8 | Shared Voting Power<br>**0.00** |
| Number of Shares<br>Beneficially Owned by<br>Each Reporting Person With: | 9 | Sole Dispositive Power<br>**244389.00** |
| Number of Shares<br>Beneficially Owned by<br>Each Reporting Person With: | 10 | Shared Dispositive Power<br>**0.00** |
| 11 | Aggregate amount beneficially owned by each reporting person<br>**244389.00** | Aggregate amount beneficially owned by each reporting person<br>**244389.00** | |
| 12 | Check if the aggregate amount in Row (11) excludes certain shares (See Instructions)<br>[ ] | Check if the aggregate amount in Row (11) excludes certain shares (See Instructions)<br>[ ] | |
| 13 | Percent of class represented by amount in Row (11)<br>**4.4%** | Percent of class represented by amount in Row (11)<br>**4.4%** | |
| 14 | Type of Reporting Person (See Instructions)<br>**OO** | Type of Reporting Person (See Instructions)<br>**OO** | |

---

**Item 1. Security and Issuer**

**(a) Title of Class of Securities:**
Common Stock

**(b) Name of Issuer:**
Axe Compute Inc.

**(c) Address of Issuer's Principal Executive Offices:**
91 43RD STREET, SUITE 110, PITTSBURGH, PA, 15201

**Item 4. Purpose of Transaction**

The Pre-Funded Warrants were acquired by Okalina Ventures LLC as an investment in the Issuer, in connection with the Issuer's Crypto PIPE financing in which the Issuer raised approximately $343.5 million through the issuance of pre-funded warrants to multiple accredited investors in exchange for cash and cryptocurrency contributions. At the time of the acquisition and exercise of the Pre-Funded Warrants, the Reporting Persons were not officers, directors, or controlling shareholders of the Issuer. The Reporting Persons exercised the Pre-Funded Warrants on December 7, 2025 via cashless exercise, resulting in the issuance of 332,002 shares of Common Stock to Okalina Ventures LLC. The Reporting Persons subsequently sold an aggregate of 87,613 shares in open market transactions during December 2025 and January 2026.

The Reporting Persons do not currently have any plans or proposals that relate to or would result in any of the transactions or changes enumerated in Items 4(a) through 4(j). The Reporting Persons may, from time to time, acquire or dispose of securities of the Issuer as they deem appropriate in light of their investment objectives and prevailing market conditions. The Reporting Persons note that as of April 1, 2026, Kyle Okamoto became President of Axe Compute Inc. and is therefore subject to the Issuer's insider trading policies, applicable securities laws, and Section 16 of the Securities Exchange Act of 1934 with respect to any future transactions in the Issuer's securities.

**Item 5. Interest in Securities of the Issuer**

**(a)**
244,389 shares of Common Stock, representing approximately 4.41% of the outstanding shares of Common Stock, based on 5,539,267 shares outstanding as of March 27, 2026, as reported in the Issuer's Annual Report on Form 10-K. At the time of the triggering event (December 7, 2025), the Reporting Persons beneficially owned 332,002 shares, representing approximately 9.78% based on 3,393,516 shares outstanding as of November 25, 2025.

**(b)**
Kyle Okamoto and Okalina Ventures LLC each have sole voting power over 244,389 shares and sole dispositive power over 244,389 shares. Neither Reporting Person has shared voting power or shared dispositive power over any shares. No other person shares voting or dispositive power with respect to these shares.

**(c)**
Okalina Ventures LLC effected the following transactions:

1. December 7, 2025 - Exercise of Pre-Funded Warrant - 332,002 shares acquired via cashless exercise at nominal exercise price of $0.01 per share - delivered via DWAC through Fidelity Brokerage Services LLC, DTC No. 0226, on Nasdaq.

2. December 26, 2025 - Open market sale - 23,242 shares sold at weighted average price of $7.02 per share - Nasdaq (AGPU) through Fidelity Brokerage Services LLC.

3. January 2, 2026 - Open market sale - 100 shares sold at weighted average price of $7.22 per share - Nasdaq (AGPU) through Fidelity Brokerage Services LLC.

4. January 13, 2026 - Open market sale - 12,883 shares sold at weighted average price of $7.14 per share - Nasdaq (AGPU) through Fidelity Brokerage Services LLC.

5. January 14, 2026 - Open market sale - 3,439 shares sold at weighted average price of $7.35 per share - Nasdaq (AGPU) through Fidelity Brokerage Services LLC.

6. January 15, 2026 - Open market sale - 47,949 shares sold at weighted average price of $8.14 per share - Nasdaq (AGPU) through Fidelity Brokerage Services LLC.

**Item 6. Contracts, Arrangements, Understandings or Relationships With Respect to Securities of the Issuer.**

1. Securities Purchase Agreement dated September 29, 2025 between Predictive Oncology, Inc. and Okalina Ventures LLC, pursuant to which Okalina Ventures LLC acquired pre-funded warrants to purchase 332,002 shares of Common Stock in exchange for 65,000,000 ATH tokens (Exhibit 99.2).

2. Pre-Funded Common Stock Purchase Warrant dated October 7, 2025 issued by Predictive Oncology, Inc. to Okalina Ventures LLC, entitling the holder to purchase up to 332,002 shares of Common Stock at a nominal exercise price of USD 0.01 per share, exercised in full via cashless exercise on December 7, 2025 (Exhibit 99.3).

3. Registration Rights Agreement dated September 2025 between Predictive Oncology, Inc. and Okalina Ventures LLC, pursuant to which the Issuer agreed to register for resale the shares of Common Stock issuable upon exercise of the Pre-Funded Warrants (Exhibit 99.4).

4. Cryptocurrency Advisory Board Agreement dated October 7, 2025 between Predictive Oncology, Inc., Okalina Ventures LLC, and Kyle Okamoto, pursuant to which Mr. Okamoto serves as a member of the Issuer's Cryptocurrency Advisory Board for cash compensation of USD 4,166 per month. This agreement was in effect at the time of the warrant exercise and remains in effect as of the date of this filing (Exhibit 99.5).

Except as described above, there are no contracts, arrangements, understandings or relationships among the Reporting Persons or between the Reporting Persons and any other person with respect to any securities of the Issuer.

### SIGNATURE

After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.

**Reporting Person:** Okamoto Kyle Robert

**Signature:** Kyle Okamoto

**Name/Title:** Kyle Okamoto

**Date:** 04/16/2026

After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.

**Reporting Person:** Okalina Ventures LLC

**Signature:** Kyle Okamoto

**Name/Title:** Kyle Okamoto / Owner

**Date:** 04/16/2026